David W Meline
CIK 1444612 · Chief Financial Officer · last filed 2026-04-20
David W Meline is a Chief Financial Officer who has filed 60 SEC Form 4 insider transactions across 6 companies since 2009. The most recent filing, for HPQ, was dated Apr 20, 2026. Across all open-market trades the lifetime net is −$4.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $18.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$18.03M
6
60
-$3.99M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HPQ | Director | 10,690 | $25.24 | $269.8K | $0 | 4 | 2026-04-20 |
| PACB | Director | 57,116 | $1.31 | $74.8K | $176.2K | 3 | 2024-06-20 |
| MRNA | Chief Financial Officer | 2,857 | $49.91 | $142.6K | -$147.7K | 6 | 2022-08-11 |
| AMGN | EVP & CFO | 49,378 | $355.20 | $17.54M | -$2.05M | 20 | 2019-11-25 |
| ZF TRW AUTOMOTIVE HOLDINGS CORP (TRW) Delisted | Director | 0 | — | — | $0 | 1 | 2015-05-15 |
| 3M CO (MMMw) Delisted | SR VP & CHIEF FINANCIAL OFCR | 32,539 | — | — | -$1.97M | 26 | 2014-02-18 |
Recent Filings
60 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-20 | HPQ | Grant (A) | — | $0 | EDGAR |
| 2025-04-16 | HPQ | Grant (A) | — | $0 | EDGAR |
| 2024-06-20 | PACB | Grant (A) | +17,116 | $0 | EDGAR |
| 2024-04-24 | HPQ | Grant (A) | +7,943 | $0 | EDGAR |
| 2024-03-06 | PACB | Buy (P) | +40,000 | $176.2K | EDGAR |
| 2023-11-03 | HPQ | Grant (A) | +2,747 | $0 | EDGAR |
| 2023-10-16 | PACB | Grant (A) | — | $0 | EDGAR |
| 2022-08-11 | MRNA | Mixed | +184 | -$28.5K | EDGAR |
| 2022-05-11 | MRNA | Mixed | +192 | $25.9K | EDGAR |
| 2022-03-03 | MRNA | Grant (A) | — | $0 | EDGAR |